Excelsior Medical Co Ltd 4104
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- NT$72.00
- Day Range
- NT$72.20–73.10
- 52-Week Range
- NT$67.30–84.58
- Bid/Ask
- NT$72.80 / NT$73.00
- Shares Outstanding
- 188.37M
- Market Cap
- NT$13.75B
- Volume/Avg
- 223,726 / 149,102
Key Statistics
- Price/Earnings (Normalized)
- 14.34
- Price/Sales
- 1.46
- Dividend Yield (Trailing)
- 5.97%
- Dividend Yield (Forward)
- 5.97%
- Dividend Payment Schedule
- May
- Total Yield
- 5.97%
Company Profile
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 774
Valuation
|
Metric
|
4104
|
|---|---|
Price/Earnings (Normalized) | 14.34 |
Price/Book Value | 1.38 |
Price/Sales | 1.46 |
Price/Cash Flow | 14.50 |
Price/Earnings
4104
Financial Strength
|
Metric
|
4104
|
|---|---|
Quick Ratio | 1.44 |
Current Ratio | 1.70 |
Interest Coverage | 33.22 |
Quick Ratio
4104
Profitability
|
Metric
|
4104
|
|---|---|
Return on Assets (Normalized) | 4.71% |
Return on Equity (Normalized) | 9.91% |
Return on Invested Capital (Normalized) | 6.42% |
Return on Assets
4104
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|<g#g>lJ | LOCK|tMMN? | $109B | |||
| Cencora Inc
COR
| LOCK|y!!?Zz% | LOCK|^##BC | $62B | |||
| Cardinal Health Inc
CAH
| LOCK|wC^Qlj> | LOCK|$!QNV | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|gdB& | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|?<@gpy | LOCK|Rq%? | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|TY | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|Rs | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|TB | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|$K%q | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|S@< | $4B |
United States